<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        62-277-99
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RAPIDUS 50 MG F.C. TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC POTASSIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        29.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="TABUK PHARMACEUTICAL MANUFACTURING CO." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            TABUK PHARMACEUTICAL MANUFACTURING CO.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 409]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Tabuk Pharmaceutical Manufacturing Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Tabuk Pharmaceutical Manufacturing Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>2. What Rapidus is and what it is used for </strong></p><p>Diclofenac potassium belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs), which are used to reduce pain and inflammation in the following conditions:</p><p>- Sprains, strains and other injuries.</p><p>- Pain and inflammation following surgery.</p><p>- Gout.</p><p>- Other painful conditions affecting the joints and muscles such as backache, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and pyrophosphate arthropathy.</p><p>The tablets can also be used to relieve the symptoms associated with migraine attacks in adults.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3. &nbsp;Before you take Rapidus</strong></p><p><strong>&nbsp; Do not take Rapidus</strong></p><p>- If you are allergic (hypersensitive) to diclofenac potassium or any of the other ingredients in the tablet.</p><p>- If you have a peptic ulcer, in your stomach (gastric) or small intestine (duodenal) or bleeding in your stomach, or have had two or more episodes of peptic ulcers, stomach bleeding or perforation.</p><p>- If you have history of gastro-intestinal bleeding or perforation, relating to previous NSAID therapy.</p><p>- If you have previously had a reaction (asthma, hives or a cold) caused by an allergy to salicylates (e.g. aspirin) or other non-steroidal pain killers.</p><p>- If you suffer from severe kidney, heart or liver failure.</p><p>- If you have established heart disease and /or cerebrovascular disease e.g. if you have had a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or brain or an operation to clear or bypass blockages.</p><p>- If you have or have had problems with your blood circulation (peripheral arterial disease).</p><p>- If you are pregnant, and in the last three months (last trimester) of pregnancy.</p><p><strong>Take special care with Rapidus</strong></p><p>C<strong>heck with your doctor or pharmacist before taking Rapidus:</strong></p><p>- If you have <strong>a history of gastrointestinal disease e.g.</strong> ulcerative colitis or Crohn&rsquo;s disease.</p><p>- If you have reduced <strong>heart, kidney,</strong> or liver function.</p><p>- If you suffer from any <strong>blood clotting</strong> disorder.</p><p>- If you have or have had <strong>asthma</strong>.</p><p>- If you suffer from liver <strong>porphyria</strong> (disorder of the red blood pigment).</p><p>- If you have had or need to have <strong>surgery</strong>.</p><p>- If you are elderly (over 65).</p><p>- If you are being treated with diuretics (water tablets) or <strong>COX-2</strong> inhibitors such as celecoxib.</p><p>- If you have <strong>Systemic Lupus Erythematosus (SLE) and mixed connective tissue disease</strong>.</p><p>Make sure your doctor knows, before you are given Rapidus:</p><p>- If you smoke.</p><p>- If you have diabetes.</p><p>- If you have angina, blood clots, high blood pressure, raised cholesterol or raised triglycerides.</p><p>Side effects may be minimised by using the lowest effective dose for the shortest duration necessary.</p><p>Medicines such as diclofenac may be associated with a small increased risk of heart attack (&ldquo;myocardial infarction&rdquo;) or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment. &nbsp;If you have heart problems, have had a previous stroke or think that you might be at risk of these conditions you should discuss your treatment with your doctor or pharmacist. <strong>Rapidus</strong> may mask the signs and symptoms of infection. Whilst you are taking these tablets, your doctor may want to give you &nbsp;a check-up from time to time.</p><p><strong>Taking other medicines</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Especially:&nbsp;</p><p><strong>- Medicines to treat</strong> diabetes, a dose adjustment of these medicines may be necessary as blood sugar may drop too low.</p><p>-<strong> Anticoagulants, (e.g. warfarin), these may increase the risk of bleeding. </strong></p><p><strong>- Diuretics </strong>(water tablets), the effect of these may be decreased. Potassium-sparing diuretics may increase the potassium levels in the blood.</p><p>- <strong>Lithium</strong> (medicine to treat depression) the blood levels of these medicines may be increased if taken with <strong>Rapidus</strong>.</p><p>- <strong>Cytotoxic</strong> medicines (e.g. methotrexate to treat cancers), should not be taken less than 24 hours before or after <strong>Rapidus</strong> tablets, the blood levels of these medicines may be increased if taken with <strong>Rapidus</strong>.</p><p>- <strong>Ciclosporin</strong>, this may harm kidney function.</p><p>- Quinolones (to treat infections, e.g. <strong>ciprofloxacin and levofloxacin</strong>) these may cause convulsions (fits).</p><p>- <strong>Steroid</strong> tablets, these may increase the risk of bleeding in the stomach.</p><p>- Other <strong>NSAIDs (e.g. aspirin), </strong>these may increase the risk of side effects.</p><p>- <strong>Medicines</strong> to treat <strong>high blood pressure</strong> (ACE-inhibitors, beta blockers), the blood pressure lowering effect may be reduced.</p><p>- <strong>Mifepristone</strong> (used to induce abortion), effect of mifepristone may be reduced by NSAIDs.</p><p>- <strong>Cardiac glycosides </strong>(e.g. digoxin) used to treat heart failure. Use with <strong>Rapidus</strong> may worsen heart failure or increase blood levels of these medicines.</p><p>- <strong>Tacrolimus</strong> (an immunosuppressant), these may increase the risk of kidney damage.</p><p>- <strong>Zidovudine</strong> (an antiretroviral drug used to treat HIV), combination with <strong>Rapidus</strong> may increase the risk of blood disorders.</p><p>- <strong>Phenytoin</strong> (a medicine used to treat seizures), the blood level of this medicine may be increased if taken with <strong>Rapidus</strong>.</p><p><strong>- Colestipol and cholestyramine, </strong>these may reduce the effect of <strong>Rapidus</strong>.</p><p>- <strong>Potent CYP2C9 Inhibitors</strong> (e.g. <strong>sulfinpyrazone and voriconazole</strong>), the blood level of <strong>Rapidus</strong> may be increased if taken with these medicines.</p><p><strong>&nbsp;- Selective serotonin reuptake inhibitors (SSRIs). </strong></p><p><strong>- Trimethoprim.</strong></p><p><strong>Laboratory tests </strong></p><p>Frequent liver and kidney function tests and monitoring of blood counts are necessary if taken for more than a few days.</p><p><strong>Pregnancy and breastfeeding </strong></p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Pregnancy</strong></p><p>It is not recommended that you take Rapidus during the first 6 months of pregnancy. However, your doctor may prescribe <strong>Rapidus</strong> for you during the first six months of pregnancy if he/she feels the benefit to you outweighs the risk. You must not however take <strong>Rapidus</strong> during the last 3 months of pregnancy as damage to the foetus and reduced labour may occur.</p><p><strong>Breastfeeding</strong></p><p>You should only use <strong>Rapidus</strong> whilst breastfeeding if advised by your doctor.</p><p><strong>Female fertility </strong></p><p><strong>Rapidus</strong> may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant.</p><p><strong>Driving and using machines</strong></p><p>Some patients may experience side effects such as dizziness, drowsiness and visual disturbances which may affect their ability to drive or operate machinery. Make sure you are not affected before driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4. How to take Rapidus &nbsp;</strong></p><p>Always take <strong>Rapidus</strong> tablets exactly as your doctor has told you. If you are unsure check with your doctor or pharmacist. <strong>Rapidus</strong> tablets must not be taken long-term, blood tests should be carried out if taken for more than a few days.&nbsp;</p><p>To minimise side-effects, you should take the lowest effective dose for the shortest time necessary to relieve your symptoms. The tablets must be swallowed whole with a glass of water, <strong>with or after food.</strong></p><p>The usual dose is:</p><p>-<strong> To treat pain and inflammation </strong></p><p><strong>- Adults</strong>, 75 mg to 150 mg a day in two or three doses.</p><p><strong>- Elderly patients, </strong>a lower dose may be used. If you are frail or have a low body weight, your doctor may ask you to go back to see him regularly for the first 4 weeks of treatment, to make sure that you are not experiencing any side effects.</p><p><strong>- Children aged 14 years and over</strong>, 75 mg to 100 mg daily, in two or three doses.</p><p><strong>- Not recommended for children under 14 years old. </strong></p><p><strong>To treat the symptoms of migraine in adults </strong>50 mg taken when the first signs of a migraine attack appear. Another 50 mg taken 2 hours after the first dose if needed and then every 4 to 6 hourly. You should not take more than 200 mg in 24 hours.</p><p><strong>These tablets are not suitable for the treatment of migraine in children.</strong></p><p><strong>If you take more Rapidus tablets than you should: </strong></p><p>Contact your doctor, emergency room or pharmacist if you have taken more Rapidus tablets than stated in this leaflet or more than what your doctor has prescribed (and you feel unwell).</p><p><strong>If you forget to take Rapidus tablets </strong></p><p>Do not take a double dose to make up for forgotten dose. Continue the treatment as advised by your doctor. If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1. Serious side effects</strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p><strong>Cardiovascular Risk </strong></p><p>NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. Rapidus is contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery. <em>Gastrointestinal Risk</em></p><p>NSAIDs cause an increased risk of serious gastrointestinal adverse events including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events &nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><strong>5. Possible side effects</strong></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>If you suffer from any of the following at any time during your treatment,</p><p><strong>STOP TAKING the medicine and seek immediate medical help: </strong></p><p>- Pass blood in your feces (stools/motions).</p><p>- Pass black tarry stools.</p><p>- Vomit any blood or dark particles that look like coffee grounds.</p><p>- An allergic reaction such as itching, low blood pressure, swelling of the face, lips, tongue, mouth and throat, which may cause shortness of breath or difficulty swallowing.</p><p>- A form of meningitis (aseptic) causing a combination of symptoms such as headache, fever, stiff neck, tiredness, muscle pain, sore throat and disorientation.</p><p>- Yellowing of the skin or the whites of your eyes.</p><p>- Stomach pain, indigestion, heartburn, wind, nausea (feeling sick), vomiting (being sick) or other abnormal stomach symptoms.</p><p>- Any type of fit or seizure.</p><p>- An unexpected change in the amount of urine produced and/or its appearance.</p><p>- Mild cramping and tenderness of the abdomen, starting shortly after the start of the treatment with <strong>Rapidus</strong> tablets and followed by rectal bleeding or bloody diarrhea usually within 24 hours of the onset of abdominal pain (frequency not known, cannot be estimated from the available data).</p><p>T<strong>ell your doctor </strong>if you experience any of the following symptoms:</p><p><strong>Common (affects up to 1 in 10 people): </strong></p><p>headache, dizziness, &rsquo;spinning&rsquo; sensation, feeling or being sick, diarrhoea, pain or swelling of your stomach or abdomen, indigestion, heartburn, wind, loss of weight or poor appetite, abnormal liver function tests, skin rashes</p><p><strong>Rare (may affect up to 1 in 1,000 people): </strong></p><p>allergic reactions, tiredness, difficulty breathing, inflammation of the stomach, stomach ulcers or bleeding, vomiting blood, blood in the faeces, hepatitis, yellowing of the skin or whites of eyes, rash or raised lumps on your skin, fluid retention (symptoms of which include swollen ankles), drowsiness.</p><p><strong>Very rare (may affect up to 1 in 10,000 people): </strong></p><p>&lsquo;pins and needles&rsquo;, tremor, blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), difficulty sleeping, nightmares, depression, irritability, anxiety, psychotic reactions, disorientation, loss of memory, seizures, aseptic meningitis, sensitivity to light, taste disturbance, constipation, inflammation of the tongue, mouth ulcers, ulcers of the gullet, lower gut disorders (including inflammation of the colon causing diarrhoea and stomach pains), palpitations (fast or irregular heart beat), chest pain, high or low blood pressure, inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), congestive heart failure, blood disorders (including anaemia, making you tired and more prone to minor infections or bleeding), kidney or liver disorders or failure, presence of blood or protein in the urine, skin rash, itching, skin eruptions, eczema, dermatitis, Erythema Multiforme (round red patches on the skin), Stevens-Johnson-Syndrome (severe skin rash with flushing, fever, blisters and ulcers), or Lyell&rsquo;s Syndrome (severe rash with reddening, peeling and swelling of skin that looks like severe burns), hair loss, pancreatitis (inflammation of the pancreas), worsening of ulcerative colitis or Crohn&rsquo;s disease, impotence (difficulty getting an erection), angioneurotic odema (swelling of the skin).</p><p><strong>Unknown (frequency cannot be estimated from the data):</strong></p><p>neutropenia (can lead to low resistance to infections), confusion, hallucination, disturbances of sensation, generally feeling unwell, sudden loss of vision. Medicines such as <strong>Rapidus</strong> tablets may be associated with a small increased risk of heart attack (&ldquo;myocardial infarction&rdquo;) or stroke (very rare). If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please inform the doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>6. How to store Rapidus </strong></p><p>&nbsp; Keep out of reach of children.</p><p>Store below 30&deg;C.</p><p>Do not use beyond the expiry date or if the product shows any sign of deterioration.</p><p>Medicines should not be disposed of via waste water or household waste.</p><p>Ask your pharmacist how to dispose of medicines no longer required.</p><p>These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>7. Further information</strong></p><p><strong>What Rapidus contains:</strong></p><p><strong>Rapidus 25 mg: </strong></p><p>Each film coated tablet contains: Diclofenac potassium 25 mg.</p><p><strong>Rapidus 50 mg: </strong></p><p>Each film coated tablet contains: Diclofenac potassium 50 mg. Excipients: Dibasic calcium phosphate anhydrous, sodium starch glycolate, copolyvidone, talc, colloidal silicon dioxide, magnesium stearate, hydroxypropyl methylcellulose, polyethylene glycol, simethicone, E171 and E172.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Presentations:
Packs of 10 or 20 Film Coated Tablets. 
Hospital packs are available.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>To report any side effect(s):</strong></p><p><strong>&bull; Saudi Arabia: </strong></p><p>National Pharmacovigilance and Drug Safety Center (NPC)</p><p>Fax: +966-11-205-7662</p><p>Call NPC at +966-11-2038222</p><p>Exts: 2317-2356-2353-2354-2334-2340</p><p>Toll free phone: 8002490000</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: www.sfda.gov.sa/npc</p><p><strong>&bull; Other GCC States:</strong></p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p><p><strong>Manufactured by: </strong></p><p><strong>TABUK PHARMACEUTICAL MANUFACTURING COMPANY,</strong></p><p><strong>MADINA ROAD, P.O. Box 3633, TABUK-SAUDI ARABIA.</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Feb. 2017
44097/R44
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>2. &nbsp;ما هو رابيدوس و ما هي دواعي استعماله</strong></p><p>ينتمي دايكلوفيناك بوتاسيوم إلى مجموعة من الأدوية تعرف بالأدوية غير الستيرويدية المضادة للالتهاب التي تستعمل لتقليل الشعور بالألم و الالتهابات في الحالات التالية:</p><p>- الالتواء، الإجهاد العضلي وأنواع الجروح الأخرى.</p><p>- الألم والالتهاب الذي يحدث بعد إجراء العملية الجراحية.</p><p>- النقرس.</p><p>- حالات مؤلمة أخرى تؤثر على المفاصل والعضلات مثل ألم الظهر، التهاب المفاصل الروماتزمي، داء مفصلي لا التهابي، التهاب الفقار القسطي و اعتلال المفصل الناتج عن ترسب بيروفسفات.</p><p>يمكن استعمال هذه الأقراص أيضاً لتخفيف الأعراض المرتبطة بحدوث نوبات شقيقة عند البالغين.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>3. &nbsp;قبل القيام بتناول رابيدوس</strong></p><p><strong>موانع استعمال &nbsp;رابيدوس</strong></p><p>- إذا كنت تعاني من الحساسية (فرط الحساسية) لدايكلوفيناك البوتاسيوم أو لأي مكونات أخرى في هذا القرص.</p><p>- إذا كنت تعاني من قرحة هضمية في المعدة (قرحة معدية) أو الأمعاء الدقيقة (الإثنى عشر) أو نزيف في المعدة، أو حصل لديك نوبتين أو أكثر من &nbsp;القرح الهضمية، نزيف أو ثقب في المعدة.</p><p>- &nbsp;إذا عانيت في السابق من نزيف أو ثقب معدي معوي نتيجة للعلاج بالأدوية غير الستيرويدية المضادة للالتهاب.</p><p>- إذا عانيت في السابق من تفاعل (الربو، الشرى أو الزكام) بسبب الحساسية لساليسيلات (مثل الأسبرين) أو مسكنات الألم غير الستيرويدية الأخرى. &nbsp;</p><p>- اذا كنت تعاني من قصور في وظيفة كل من الكلى، القلب، أو الكبد.</p><p>- اذا كنت تعاني من مرض قلبي مثبت و/أو مرض مخي وعائي مثلاً إذا عانيت في السابق من نوبة قلبية، سكتة دماغية، السكتة الدماغية التي تستمر لفترة قصيرة (النوبة المؤقتة الناتجة عن توقف تدفق الدم إلى الدماغ لفترة قصيرة) أو حدوث انسداد في الأوعية الدموية التي تغذي القلب أو الدماغ أو خضعت لعملية الترقيع التحويلية للشرايين. &nbsp;</p><p>- إذا كنت تعاني أو عانيت في السابق من مشاكل في الدورة الدموية (مرض الشرايين الطرفية). &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p><p>- إذا كنتِ حامل، وفي الأشهر الثلاتة الأخيرة من الحمل.</p><p><strong>الاحتياطات عند تناول رابيدوس</strong></p><p><strong>تأكد من الطبيب أو الصيدلاني قبل تناول رابيدوس: </strong></p><p>- إذا عانيت في السابق من مرض معدي معوي مثل التهاب القولون التقرحي أو مرض كرون.</p><p>- إذا عانيت من انخفاض في كفاءة وظيفة <strong>القلب، الكلى، أو الكبد. </strong></p><p>- إذا كنت تعاني من أي اضطراب في <strong>تجلط الدم. </strong></p><p>- إذا كنت تعاني أو عانيت في السابق من الربو.</p><p>- إذا كنت تعاني من برفرية الكبد (اضطراب الصبغة الحمراء للدم).</p><p>- إذا كنت قد قمت بعملية جراحية أو بحاجة للقيام بعملية جراحية.</p><p>- إذا كنت من كبار السن (فوق ال 65 سنة).</p><p>- إذا كنت تخضع للعلاج بمدرات <strong>البول</strong> (أقراص الماء) أو <strong>مثبطات سايكلو أوكسيجينيز</strong>-2 مثل سيليكوكسيب.</p><p>- إذا كنت تعاني من مرض <strong>الذأب الحمامي الجهازي أو مرض النسيج الضام المختلط. </strong></p><p>تأكد من إخبار الطبيب، قبل إعطائك <strong>رابيدوس</strong>:</p><p>- إذا كنت مدخناً.</p><p>&nbsp; - إذا كنت تعاني من داء السكري.</p><p>&nbsp; - إذا كنت تعاني من ذبحة صدرية، جلطات دموية، ارتفاع ضغط الدم، ارتفاع الكوليستيرول &nbsp;أو الجليسيريدات الثلاثية.</p><p>يمكن تقليل حصول الآثار الجانبية باستعمال أقل جرعة فعالة لأقصر فترة ممكنة. &nbsp; قد تكون الأدوية مثل الدايكلوفيناك بوتاسيوم مرتبطة بارتفاع خطر حدوث نوبة قلبية (&quot;احتشاء عضلة القلب&quot;) أوسكتة دماغية. تزداد نسبة حدوث هذه المخاطر عند تناول الجرعات العالية والاستعمال طويل الأمد. لا تتجاوز الجرعة الموصى بها أو مدة الاستعمال الموصى بها.</p><p>إذا كانت تعاني من مشاكل في القلب، أو عانيت في السابق من سكتة دماغية أو كنت تعتقد بأنك معرض لخطر حصول هذه الحالات لديك يجب عليك مناقشة العلاج مع الطبيب أو الصيدلاني.</p><p>يمكن <strong>لرابيدوس</strong> أن يخفي علامات وأعراض الالتهاب.</p><p>خلال فترة تناولك لهذه الأقراص، قد يطلب منك الطبيب مراجعته من وقت لآخر.</p><p><strong>تناول أدوية أخرى </strong></p><p>أخبر الطبيب أو الصيدلاني إذا كنت تتناول أو تناولت مؤخراً أي أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها بدون وصفة طبية.</p><p>بشكل خاص الأدوية التالية:</p><p><strong>- أدوية لعلاج داء السكري،</strong> قد يكون من الضروري تعديل جرعة هذه الأدوية، حيث ينخفض مستوى السكر في الدم بشكل كبير.</p><p>- <strong>مضادات التجلط (مثل الوارفارين)، قد تزيد هذه الأدوية خطورة حدوث النزيف.</strong></p><p>- <strong>مدرات البول</strong> (أقراص الماء)، قد تقل فعالية هذه الأدوية.</p><p>قد تزيد مدرات البول الحافظة للبوتاسيوم من مستويات البوتاسيوم في الدم.</p><p>- <strong>ليثيوم</strong> (دواء يستعمل لعلاج الاكتئاب) قد تزداد مستويات هذه الأدوية في الدم عند تناولها بشكل متزامن مع <strong>رابيدوس</strong>.</p><p>- <strong>الأدوية السامة للخلايا</strong> (مثل ميثوتريكسيت المستعمل لعلاج السرطان)، يجب عدم تناوله قبل أو بعد 24 ساعة على الأقل من تناول أقراص <strong>رابيدوس</strong>. &nbsp;</p><p>- <strong>سايكلوسبورين</strong>، حيث قد يؤثر هذا الدواء على وظائف الكلى.</p><p>- <strong>الكوينولون</strong> (لعلاج الالتهابات مثل سيبروفلوكساسين وليفوفلوكساسين) قد تؤدي هذه الأدوية إلى حدوث تشنجات (نوبات ظهور أعراض مفاجئة).&nbsp;</p><p>- الأقراص الستيرويدية، قد تزيد هذه الأدوية من خطورة حدوث نزيف في المعدة .</p><p>- الأدوية غير الستيرويدية المضادة للالتهاب الأخرى (مثل الأسبرين)، قد تزيد هذه الأدوية من خطورة حدوث الآثار الجانبية. &nbsp;</p><p>- الأدوية التي تستعمل لعلاج ارتفاع ضغط الدم (مثبط الإنزيم المحوِّل للأنجيوتنسين، حاصرات بيتا) قد يقل مفعول الأدوية الخافض لضغط الدم.</p><p>- ميفيبريستون (تستخدم لتحفيز الإجهاض)، قد يقل تأثير ميفيبريستون إذا استعمل بشكل متزامن مع الأدوية غير الستيرويدية المضادة للالتهاب.</p><p>- الجلايكوسيدات القلبية (مثل ديجوكسين) تستعمل لعلاج قصور عضلة القلب. قد يزيد استعمالها بشكل متزامن مع رابيدوس من حالة قصور عضلة القلب سوءاً أو يزيد من مستويات هذه الأدوية في الدم.</p><p>- <strong>تاكروليمس</strong> (كابت للمناعة)، قد تزيد هذه الأدوية من خطر التعرض لتلف الكلية. &nbsp;</p><p>- <strong>زيدوفودين</strong> (دواء مضاد للفيروسات يستعمل لعلاج مرض نقص المناعة المكتسبة)، قد يزيد استعماله بشكل متزامن مع <strong>رابيدوس</strong> من خطورة التعرض لاضطرابات في الدم.</p><p>- <strong>فينيتوين</strong> (دواء يستعمل لعلاج نوبات الصرع)، قد يزيد مستوى هذا الدواء في الدم عند تناوله بشكل متزامن مع <strong>رابيدوس</strong>. &nbsp;</p><p>- كوليستيبول وكوليستيرامين، حيث قد تقلل هذه الأدوية من مفعول <strong>رابيدوس</strong>.</p><p>- مثبطات <strong>CYP2C9 &nbsp;القوية (مثل سالفين بيرازون وفوريكونازول)</strong>، قد يزيد مستوى <strong>رابيدوس</strong> في الدم عند تناوله بشكل متزامن مع هذه الأدوية.</p><p><strong>- مثبطات إعادة امتصاص السيروتونين الانتقائية.</strong></p><p><strong>- ترايميثوبرايم.</strong></p><p><strong>فحوصات المختبر </strong></p><p>من الضروري القيام بفحوصات وظائف الكلى و مراقبة تعدادات الدم إذا تم تناول هذا الدواء لفترة تزيد عن بضعة أيام. &nbsp;</p><p><strong>الحمل والإرضاع </strong></p><p>استشيري الطبيب أو الصيدلاني قبل تناول أي دواء.</p><p><strong>الحمل</strong></p><p>لا يوصى بتناول رابيدوس خلال الأشهر الستة الأولى من الحمل. مع ذلك، قد يقوم الطبيب بوصف رابيدوس لك خلال الأشهر الستة الأولى من الحمل إذا كانت الفائدة المرجوة تفوق الخطورة المتوقعة. على كل حال، يجب عليك عدم تناول رابيدوس خلال الأشهر الثلاثة الأخيرة من الحمل حيث قد يحدث ضرر للجنين ويقلل المخاض.&nbsp;</p><p><strong>لارضاع</strong></p><p>من الممكن استعمال رابيدوس خلال فترة الإرضاع فقط إذا أوصى الطبيب بذلك.</p><p><strong>خصوبة المرأة </strong></p><p>يمكن أن يزيد تناول رابيدوس من صعوبة حصول الحمل.</p><p>يجب عليك إخبار الطبيب إذا كنت تخططين للحمل أو كان لديك مشاكل في حصول الحمل.</p><p>قيادة المركبات و استخدام الآلات</p><p>قد يحصل لدى بعض المرضى آثار جانبية مثل شعور بدوخة، نعاس واضطرابات بصرية التي قد تؤثر على قدرتهم على القيادة أو تشغيل الآلات. تأكد من عدم تأثرك بذلك قبل القيادة أو تشغيل الآلات.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>4. &nbsp;ما هي طريقة تناول رابيدوس </strong></p><p>&nbsp;تناول <strong>أقراص رابيدوس</strong> تماماً كما أخبرك الطبيب. إذا لم تكن متأكداً اسأل الطبيب أو الصيدلاني. يجب عدم استعمال أقراص <strong>رابيدوس</strong> لفترة طويلة. يجب القيام بفحوصات الدم إذا تم تناول هذا الدواء لفترة تزيد عن بضعة أيام. لتقليل الآثار الجانبية، يجب تناول أقل جرعة فعّالة لأقصر فترة لازمة لتخفيف الأعراض.</p><p>يجب تناول هذه الأقراص كاملة مع كأس من الماء، <strong>مع أو بعد تناول الطعام.</strong></p><p>الجرعة المعتادة هي:</p><p><strong>لعلاج الألم والالتهاب</strong></p><p>- <strong>البالغون</strong>، 75 ملجم إلى 150 ملجم يومياً مقسمة على جرعتين أو ثلاث جرعات.</p><p>- <strong>المرضى كبار السن</strong>، من الممكن استعمال جرعة أقل. إذا كنت ضعيف البنية أو وزن الجسم لديك منخفض. قد يطلب منك الطبيب زيارته بشكل دوري خلال الأربع أسابيع الأولى من العلاج، للتأكد من عدم حصول أي آثار جانبية لديك.</p><p><strong>- الأطفال الذين تبلغ أعمارهم 14 سنة فما فوق</strong>، 75 ملجم إلى 100 ملجم يومياً، مقسمة على جرعتين أو ثلاث جرعات</p><p>- لا يوصى باستعماله للأطفال الذين تقل أعمارهم عن 14 سنة.</p><p><strong>لعلاج أعراض الشقيقة عند البالغين </strong></p><p>يتم تناول 50 ملجم عند ظهور أول علامات لنوبة الشقيقة. ثم يتم تناول جرعة أخرى 50 ملجم بعد ساعتين من تناول الجرعة الأولى إذا لزم الأمر وبعد ذلك كل 4 إلى 6 ساعات. يجب عدم تناول أكثر من 200 ملحم خلال 24 ساعة.</p><p><strong>هذه الأقراص غير مناسبة لعلاج الشقيقة عند الأطفال.</strong></p><p><strong>إذا تناولت رابيدوس أكثر مما يجب </strong></p><p>قم بالاتصال بالطبيب أو غرفة الطوارئ أو الصيدلاني إذا قمت بتناول أقراص <strong>رابيدوس</strong> أكثر مما ذكر في النشرة أو أكثر من الجرعة التي قام الطبيب بوصفها &nbsp;لك (وتشعر بأنك لست على ما يرام).</p><p>إذا نسيت تناول جرعة <strong>رابيدوس</strong></p><p>لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها. استمر بالعلاج كما أوصى الطبيب.</p><p>إذا كان لديك أي أسئلة إضافية عن استعمال هذا الدواء، اسأل الطبيب أو الصيدلاني. &nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><strong>1. &nbsp;الآثار الجانبية الخطيرة</strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>ا<strong>لخطورة على الجهاز القلبي الوعائي و الجهاز المعدي المعوي </strong></p><p><strong>الخطورة على الجهاز القلبي الوعائي: </strong></p><p><strong>-</strong> قد يسبب رابيدوس زيادة خطورة أعراض تخثر الجهاز القلبي الوعائي الخطيرة، الاحتشاء العضلي القلبي، و السكتة الدماغية، التي قد تؤدي إلى الوفاة. جميع الأدوية غير الستيرويدية المضادة للالتهاب لها نفس الخطورة. تزداد هذه الخطورة مع طول فترة الاستعمال. المرضى الذين يعانون من أمراض الجهاز القلبي الوعائي أو الذين لديهم قابلية أو احتمال للإصابة بها، معرضون بشكل أكبر للخطورة.</p><p>- يمنع استعمال رابيدوس لعلاج الألم في محيط العملية عند البدء بعملية الترقيع التحويلية للشرايين التاجية.</p><p><strong>الخطورة على الجهاز المعدي المعوي: </strong></p><p>تتسبب الأدوية غير الستيرويدية المضادة للالتهاب بما فيها رابيدوس بزيادة الآثار الجانبية الخطيرة على الجهاز المعدي المعوي، بما فيها الالتهاب، النزيف، التقرح، و حدوث ثقب في المعدة أو الأمعاء، والتي قد تؤدي إلى الوفاة. قد تحدث هذه الآثار في أي وقت أثناء فترة الاستعمال و بدون حدوث أعراض تحذيرية. كبار السن معرضون أكثر للإصابة بهذه الآثار الجانبية الخطيرة للجهاز المعدي المعوي. &nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>5. الآثار الجانبية المحتملة </strong></p><p>مثل كل الأدوية، قد يسبب هذا الدواء آثاراً جانبية على الرغم من عدم حدوثها لدى الجميع.</p><p>إذا عانيت من أي من الآثار الجانبية التالية في أي وقت خلال فترة العلاج، توقف عن تناول الدواء واطلب الرعاية الطبية فوراً:</p><p>- ظهور دم في البراز.</p><p>- إخراج براز أسود قطراني.</p><p>- تقيؤ الدم أو حبيبات صغيرة داكنة تشبه حبيبات القهوة.</p><p>- تفاعل تحسسي مثل الحكة، انخفاض ضغط الدم، تورم الوجه، الشفاه، اللسان، الفم والحلق الذي قد يسبب قصر النفس أو صعوبة في البلع.</p><p>- نوع من أنواع التهاب السحايا (غير البكتيري) يسبب حدوث مجموعة من الأعراض مثل شعور بالصداع، الحمى، تيبس الرقبة، التعب، ألم في العضلات، التهاب الحلق، والارتباك.</p><p>- اصفرار الجلد أو المنطقة البيضاء في العيون.</p><p>- ألم المعدة، عسر الهضم، حرقة، انتفاخ البطن، شعور بالغثيان، قيء، أو أعراض غير طبيعية أخرى في المعدة.&nbsp; &nbsp; &nbsp;</p><p>- أي نوع من أنواع النوبات التي تظهر بشكل مفاجىء أو نوبات الصرع.</p><p>- تغير غير متوقع في كمية البول المنتج و/أو تغير مظهره.</p><p>- تشنج طفيف وتألم عند لمس البطن، تحدث بعد فترة قصيرة من بدء العلاج بأقراص رابيدوس ويتبع بنزيف من الشرج أو إسهال مصحوب بالدم عادةً خلال 24 ساعة من بدء الألم في منطقة البطن (تكرار الحدوث غير معروف، لا يمكن تقديره من البيانات المتوافرة).</p><p><strong>أخبر الطبيب إذا حصل لديك أي من الأعراض التالية: </strong></p><p><strong>شائعة (قد تؤثر على 1 أو أقل من كل 10 أشخاص): </strong></p><p>صداع، دوخة، شعور بالدوار، شعور بالغثيان أو القيء، إسهال، ألم أو تورم في المعدة أو البطن، عسر الهضم، حرقة، انتفاخ البطن، فقدان الوزن أو فقدان الشهية، اضطراب في &nbsp;وظيفة الكبد، طفح جلدي.</p><p><strong>نادرة (قد تؤثر على 1 أو أقل من كل 1000 شخص): </strong></p><p>تفاعلات تحسسية، شعور بالتعب، صعوبة في التنفس، التهاب المعدة، قرحة أو نزيف المعدة، تقيؤ الدم، ظهور ظهور دم في البراز، التهاب الكبد، اصفرار الجلد أو المنطقة البيضاء في العيون، طفح جلدي أو ظهور كتل بارزة على سطح الجلد، احتباس السوائل (أعراضه التي تشمل تورم الكاحلين)، شعور بالنعاس.</p><p><strong>نادرة جداً (قد تؤثر على 1 أو أقل من كل 10000 شخص): </strong></p><p>الإحساس بوخز خفيف، رعاش، ضبابية أو ازدواجية الرؤية، ضعف أو فقدان السمع، طنين (رنين في الأذن)، صعوبة القدرة على النوم، كوابيس، اكتئاب، سرعة الغضب، قلق، ردود أفعال نفسية، ارتباك، فقدان الذاكرة، نوبات صرع، التهاب السحايا غير البكتيري، الحساسية للضوء، اضطراب حاسة التذوق، إمساك، التهاب اللسان، تقرحات الفم، تقرحات المريء، اضطراب القناة الهضمية السفلى (بما في ذلك التهاب القولون الذي يسبب الإسهال وآلام المعدة)، خفقان (نبضات القلب سريعة أو غير منتظمة)، ألم في الصدر، ارتفاع أو انخفاض ضغط الدم، التهاب الأوعية الدموية، التهاب الرئة، قصور القلب الاحتقاني، واضطرابات الدم (بما في ذلك فقر الدم، حيث يجعلك متعبا وأكثر عرضة للإلتهابات البسيطة أو النزيف)، اضطرابات أو قصور في وظيفة الكلى و الكبد، ظهور دم أو بروتين في البول، طفح جلدي، حكة، تهيج الجلد، أكزيما، التهاب الجلد ، حمامى متعددة الأشكال (ظهور بقع حمراء دائرية على الجلد)، متلازمة ستيفن-جونسون (طفح جلدي حاد مع احمرار، والحمى، وظهور بثور وتقرحات)، أو متلازمة ليل (طفح حاد مع احمرار، تقشر وتورم الجلد الذي يشبه الحروق الحادة)، فقدان الشعر، التهاب البنكرياس، تفاقم التهاب القولون التقرحي أو مرض كرون، الضعف الجنسي (صعوبة الحصول على الانتصاب)، أوديما وعائية عصبية (تورم الجلد).</p><p><strong>غير معروفة (لا يمكن تقدير تكرار حدوثها من البيانات المتوافرة)&nbsp; </strong></p><p>قلة الخلايا المتعادلة (يمكن أن تؤدي إلى انخفاض المقاومة للالتهابات)، ارتباك، هلوسة، اضطرابات الإحساس، شعور عام بالمرض، فقدان مفاجئ للرؤية. قد يرتبط استعمال الأدوية مثل أقراص رابيدوس بزيادة بسيطة في إمكانية حدوث نوبة قلبية (&quot;احتشاء عضلة القلب&quot;) أو سكتة دماغية (نادرة جداً). إذا ازدادت حدة أي من الآثار الجانبية، أو إذا لاحظت أي آثار جانبية غير مذكورة في هذه النشرة، الرجاء أن تخبر طبيبك أو الصيدلاني.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>6. ظروف تخزين رابيدوس </strong></p><p>يحفظ بعيداً عن متناول الأطفال.</p><p>يحفظ في درجة حرارة أقل من 30 &deg;م.</p><p>لا تستعمل الدواء بعد انتهاء مدة صلاحيته أو عند ملاحظة أي علامة تلف فيه.</p><p>يجب عدم التخلص من أي أدوية عن طريق رميها في المياه العادمة أو النفايات المنزلية. استشر الصيدلاني عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. سوف تساعد هذه التدابير في حماية البيئة.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>7. معلومات إضافية </strong></p><p><strong>ماذا يحتوي رابيدوس:</strong></p><p><strong>رابيدوس 25 ملجم:</strong> يحتوي كل قرص مغلف على: دايكلوفيناك بوتاسيوم 25 ملجم.</p><p><strong>رابيدوس 05 ملجم:</strong> يحتوي كل قرص مغلف على: دايكلوفيناك بوتاسيوم 50 ملجم. &nbsp;</p><p>السواغات: دايبيسك كالسيوم فوسفات لا مائي، صوديوم جلايكولات النشا، كوبوليفيدون، تلك، ثاني أوكسيد السيليكون الغروي، ستيرات المغنيسيوم، هيدروكسي بروبيل مثيل سيلييلوز، بولي إيثيلين جلايكول، سيميثيكون، E172، E171</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>العبوات: </strong></p><p>عبوات تحتوي على 10 أو 20 قرصاً مغلفاً.</p><p>تتوفر عبوات خاصة بالمستشفيات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>للقيام بالإبلاغ عن أي من الأعراض الجانبية:</strong></p><p><strong>&bull; المملكة العربية السعودية: </strong></p><p>المركز الوطني للتيقظ و السلامة الدوائية</p><p>فاكس: 7662-205-11-966+</p><p>للإتصال بالإدارة التنفيذية للتيقظ و إدارة الأزمات</p><p>هاتف: 2038222-11-966+</p><p>تحويلة: 2340-2334-2354-2353-2356-2317 &nbsp;</p><p>الهاتف المجاني: 8002490000</p><p>البريد الالكتروني: npc.drug@sfda.gov.sa</p><p>الموقع الالكتروني: www.sfda.gov.sa/npc</p><p><strong>&bull; دول الخليج الأخرى: </strong></p><p>الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة.</p><p>&nbsp;</p><p><strong>إنتاج: </strong></p><p><strong>شركة تبوك للصناعات الدوائية، طريق المدينة، </strong></p><p><strong>ص.ب 3633، تبوك-المملكة العربية السعودية.</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            Feb. 2017
44097/R44
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rapidus 50 mg Film Coated Tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains 50 mg diclofenac potassium.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Reddish Brown colored, 8.0 mm round , biconvex, film Coated tablets engraved with “IK” on one side and plain on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rheumatoid arthritis</p><p>Osteoarthrosis</p><p>Low back pain</p><p>Migraine attacks</p><p>Acute musculo-skeletal disorders and trauma such as periarthritis (especially frozen shoulder),</p><p>tendinitis, tenosynovitis, bursitis, sprains, strains and dislocations; relief of pain in fractures</p><p>Ankylosing spondylitis</p><p>Acute gout</p><p>Control of pain and inflammation in orthopaedic, dental and other minor surgery</p><p>Pyrophosphate arthropathy and associated disorders</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For oral administration.</p><p>To be taken preferably with or after food.</p><p>The tablets should be swallowed whole with liquid</p><p>Undesirable effects may be minimised by using the lowest effective dose for the</p><p>shortest duration necessary to control symptoms (see section 4.4)</p><p>Adults</p><p>The recommended daily dose is 100 &ndash; 150 mg in two or three divided doses. For milder</p><p>cases, 75 &ndash; 100 mg daily in two or three divided doses is usually sufficient.</p><p>In migraine an initial dose of 50 mg should be taken at the first signs of an impending</p><p>attack. In cases where relief 2 hours after the first dose is not sufficient, a further dose of</p><p>50 mg may be taken. If needed, further doses of 50 mg may be taken at intervals of 4 &ndash; 6</p><p>hours, not exceeding a total dose of 200 mg per day.</p><p>Pediatric population</p><p>For children over 14 years of age, the recommended daily dose is 75 &ndash; 100 mg in two or</p><p>three divided doses. Diclofenac Potassium 25 mg tablets are not recommended for children</p><p>under 14 years of age. The use of Diclofenac Potassium 50 mg tablets in migraine attacks</p><p>has not been established in children.</p><p>Elderly</p><p>The elderly are at increased risk of the serious consequences of adverse reactions. If an</p><p>NSAID is considered necessary, the lowest effective dose should be used and for the</p><p>shortest possible duration. The patient should be monitored regularly for GI bleeding</p><p>during NSAID therapy.</p><p>Renal impairment</p><p>No adjustment of the starting dose is required for renally impaired patients (see section</p><p>4.4).</p><p>Hepatic impairment</p><p>No adjustment of the starting dose is required for hepatically impaired patients (see section</p><p>4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Hypersensitivity to the active substance or any of the excipients.
- Active, gastric or intestinal ulcer, bleeding or perforation.
- Active, or history of recurrent peptic ulcer / haemorrhage (two or more distinct episodes of
proven ulceration or bleeding).
- NSAIDs are contraindicated in patients who have previously shown hypersensitivity
reactions (e.g. asthma, rhinitis, angioedema, or urticaria) in response to ibuprofen, aspirin, or
other non-steroidal anti-inflammatory drugs.
- Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial
disease and/or cerebrovascular disease.
- Severe heart failure, hepatic failure and renal failure (see section 4.4).
- History of gastro-intestinal bleeding or perforation, relating to previous NSAID therapy.
- During the last trimester of pregnancy (see section 4.6).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest</p><p>duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks below).</p><p>The use of Diclofenac potassium with concomitant NSAIDs including cyclooxygenase-2</p><p>selective inhibitors should be avoided due to the absence of any evidence demonstrating</p><p>synergistic benefits and the potential for additive undesirable effects (see section 4.5).</p><p>Elderly</p><p>Caution is indicated in the elderly on basic medical grounds. The elderly have increased</p><p>frequency of adverse reactions to NSAIDs especially gastro intestinal bleeding and perforation</p><p>which may be fatal. In particular, it is recommended that the lowest effective dose be used in</p><p>frail elderly patients or those with a low body weight (see section 4.2).&nbsp;</p><p>Gastrointestinal</p><p>Close medical surveillance is imperative in patients with symptoms indicative of gastrointestinal</p><p>disorders, with a history suggestive of gastric or intestinal ulceration, bleeding or perforation,</p><p>with ulcerative colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see</p><p>section 4.8).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual</p><p>abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.</p><p>GI bleeding (haematemesis, melaena), ulceration or perforation, which can be fatal, has been</p><p>reported with all NSAIDs at any time during treatment, with or without warning symptoms or a</p><p>previous history of serious GI events. They generally have more serious consequences in the</p><p>elderly.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in</p><p>patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see</p><p>section 4.3), and in the elderly. These patients should commence and maintain treatment on the</p><p>lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton</p><p>pump inhibitors) should be considered for these patients, and also for patients requiring</p><p>concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below</p><p>and section 4.5).</p><p>Caution should be advised in patients receiving concomitant medications which increase the risk</p><p>of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective</p><p>serotonin-reuptake inhibitors or anti-platelet agents such as aspirin (see section 4.5).</p><p>When GI bleeding or ulceration occurs in patients receiving diclofenac potassium, the treatment</p><p>should be withdrawn.</p><p>NSAID</p><p>Hypersensitivity reactions</p><p>As with other non-steroidal anti-inflammatory drugs, allergic reactions, including</p><p>anaphylactic/anaphylactoid reactions, can occur without earlier exposure to the drug (see section</p><p>4.8).</p><p>Infection</p><p>Like other NSAIDs, Diclofenac Potassium tablets may mask the signs and symptoms of</p><p>infection due to their pharmacodynamic properties.</p><p>SLE and mixed connective tissue disease:</p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there</p><p>may be an increased risk of aseptic meningitis (see section 4.8).</p><p>Cardiovascular, Renal and Hepatic Impairment:</p><p>The administration of an NSAID may cause a dose dependent reduction in prostaglandin</p><p>formation and precipitate renal failure.</p><p>As fluid retention and oedema have been reported in association with NSAIDs therapy, including</p><p>diclofenac, particular caution is called for in patients with impaired cardiac or renal function,</p><p>history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or</p><p>medicinal products that can significantly impact renal function, and those patients with</p><p>substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see</p><p>section 4.3). Monitoring of renal function is recommended as a precautionary measure when</p><p>using diclofenac in such cases. Discontinuation therapy is usually followed by recovery to the</p><p>pre-treatment state.</p><p>Hepatic</p><p>Close medical surveillance is required when prescribing diclofenac to patients with impairment</p><p>of hepatic function as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase.</p><p>During prolonged treatment with Diclofenac, regular monitoring of hepatic function is indicated</p><p>as a precautionary measure. If abnormal liver function tests persist or worsen, clinical signs or</p><p>symptoms consistent with liver disease develop or if other manifestations occur (eosinophilia,</p><p>rash), Diclofenac Potassium tablets should be discontinued.</p><p>Hepatitis may occur without prodromal symptoms.</p><p>Use of Diclofenac Potassium tablets in patients with hepatic porphyria may trigger an attack.</p><p>Haematological</p><p>Diclofenac Potassium tablets may reversibly inhibit platelet aggregation (see section 4.5).</p><p>Patients with defects of haemostasis, bleeding diathesis or haematological abnormalities should</p><p>be carefully monitored.</p><p>Long term treatment</p><p>All patients who are receiving long term treatment with non-steroidal, anti-inflammatory agents</p><p>should be monitored as a precautionary measure eg renal function, hepatic function (elevation of</p><p>liver enzymes may occur) and blood counts. This is particularly important in the elderly.</p><p>Respiratory disorders</p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal</p><p>polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract</p><p>(especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma</p><p>exacerbations (so called intolerance to analgesics / analgesics asthma), Quincke&#39;s oedema or</p><p>urticaria are more frequent than in other patients. Therefore, special precaution is recommended</p><p>in such patients (readiness for emergency). This is applicable as well for patients who are</p><p>allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p><p>Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other</p><p>NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a</p><p>previous history of bronchial asthma.</p><p>Cardiovascular and cerebrovascular effects</p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or</p><p>mild to moderate congestive heart failure as fluid retention and oedema have been reported in</p><p>association with NSAID therapy including diclofenac.</p><p>Clinical trial and epidemiological data suggest that use of diclofenac, particularly at high dose</p><p>(150mg daily) and in long term treatment may be associated with a small increased risk of</p><p>arterial thrombotic events (for example myocardial infarction or stroke).</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart</p><p>disease, peripheral arterial disease, and/or cerebrovascular disease and with significant risk</p><p>factors for cardiovascular events (e.g.,, hyperlipidaemia, diabetes mellitus, smoking) should only</p><p>be treated with diclofenac after careful consideration.</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the</p><p>shortest duration possible and the lowest effective daily dose should be used. The patient&#39;s need</p><p>for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>Dermatological</p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens- Johnson</p><p>syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the</p><p>use of NSAIDs (see section 4.8). Patients appear to be at highest risk for these reactions early in</p><p>the course of therapy: the onset of the reaction occurring in the majority of cases within the first</p><p>month of treatment. Diclofenac potassium should be discontinued at the first appearance of skin</p><p>rash, mucosal lesions, or any other sign of hypersensitivity.</p><p>Impaired female fertility</p><p>The use of Diclofenac Potassium tablets may impair female fertility and is not recommended in</p><p>women attempting to conceive. In women who may have difficulties conceiving or who are</p><p>undergoing investigation of infertility, withdrawal of Diclofenac Potassium tablets should be</p><p>considered (see section 4.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids:</p><p>Co-administration of diclofenac with other systemic NSAIDs or corticosteroids may increase the</p><p>risk of gastrointestinal bleeding or ulceration. Avoid concomitant use of two or more NSAIDs</p><p>(see section 4.4).</p><p>Diuretics and antihypertensive agents: Like other NSAIDs, concomitant use of diclofenac with</p><p>diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE)</p><p>inhibitors may cause a decrease in their antihypertensive effect via inhibition of vasodilatory</p><p>prostaglandin synthesis.</p><p>Therefore, the combination should be administered with caution and patients, especially the</p><p>elderly, should have their blood pressure periodically monitored. Patients should be adequately</p><p>hydrated and consideration should be given to monitoring of renal function after initiation of</p><p>concomitant therapy periodically thereafter, particularly for diuretics and ACE inhibitors due to</p><p>the increased risk of nephrotoxicity.(see section 4.4)</p><p>Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma</p><p>glycoside levels.</p><p>Lithium: If used concomitantly, diclofenac may increase plasma concentrations of lithium</p><p>Monitoring of the serum lithium level is recommended.</p><p>Methotrexate: Diclofenac can inhibit the tubular renal clearance of methotrexate hereby</p><p>increasing methotrexate levels. Caution is recommended when NSAIDs, including diclofenac,</p><p>are administered less than 24 hours before treatment with methotrexate, since blood</p><p>concentrations of methotrexate may rise and the toxicity of this substance be increase. Cases of</p><p>serious toxicity have been reported when methotrexate and NSAIDs including diclofenac are</p><p>given within 24 hours of each other. This interaction is mediated through accumulation of</p><p>methotrexate resulting from impairment of renal excretion in the presence of the NSAID.</p><p>Ciclosporin: Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due</p><p>to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that</p><p>would be used in patients not receiving ciclosporin.</p><p>Mifepristone: NSAIDs should not be used for 8-12 days after mifepristone administration as</p><p>NSAIDs can reduce the effect of mifepristone.</p><p>Anti-coagulants and anti-platelet agents: Caution is recommended since concomitant</p><p>administration could increase the risk of bleeding (see section 4.4). Although clinical</p><p>investigations do not appear to indicate that diclofenac has an influence on the effect of</p><p>anticoagulants, there are reports of an increased risk of haemorrhage in patients receiving</p><p>diclofenac and anticoagulant concomitantly (see section 4.4). Therefore, to be certain that no</p><p>change in anticoagulant dosage is required, close monitoring of such patients is required. As with</p><p>other nonsteroidal anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit</p><p>platelet aggregation.NSAID</p><p>Digoxin: If used concomitantly, diclofenac may raise plasma concentrations of digoxin.</p><p>Monitoring of the serum digoxin level is recommended.&nbsp;</p><p>Selective serotonin reuptake inhibitors (SSRls): lncreased risk of gastrointestinal bleeding (see</p><p>section 4.4).</p><p>Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</p><p>This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin</p><p>inhibitor.</p><p>Quinolone antibacterials: Convulsions may occur due to an interaction between quinolones and</p><p>NSAIDs. This may occur in patients with or without a previous history of epilepsy or</p><p>convulsions. Therefore, caution should be exercised when considering the use of a quinolone in</p><p>patients who are already receiving an NSAID.</p><p>Phenytoin: When using phenytoin concomitantly with diclofenac, monitoring of phenytoin</p><p>plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p>Colestipol and cholestyramine: These agents can induce a delay or decrease in absorption of</p><p>diclofenac.</p><p>Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours</p><p>after administration of colestipol/ cholestyramine.</p><p>Zidovudine: lncreased risk of haematological toxicity when NSAIDs are given with zidovudine.</p><p>There is evidence of an increased risk of haemarthroses and haematoma in HIV(+)</p><p>haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p><p>Antidiabetic agents: Clinical studies have shown that Diclofenac Potassium tablets can be given</p><p>together with oral antidiabetic agents without influencing their clinical effect. However there</p><p>have been isolated reports of hypoglycaemic and hyperglycaemic effects which have required</p><p>adjustment to the dosage of hypoglycaemic agents. For this reason, monitoring of the blood</p><p>glucose level is recommended as a precautionary measure during concomitant therapy.</p><p>Drugs known to cause hyperkalemia: Concomitant treatment with potassium-sparing diuretics,</p><p>ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium</p><p>levels, which should therefore be monitored frequently (see section 4.4).</p><p>Potent CYP2C9 inhibitors: Caution is recommended when co-prescribing diclofenac with potent</p><p>CYP2C9 inhibitors (such as voriconazole), which could result in a significant increase in peak</p><p>plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellpadding="0" style="width:632px"><tbody><tr><td><p>Pregnancy Category C</p><p>Congenital abnormalities have been reported in association with NSAID administration in</p><p>man; however, these are low in frequency and do not appear to follow any discernible</p><p>pattern. In view of the known effects of NSAIDs on the foetal cardiovascular system (risk of</p><p>closure of the ductus arteriosus), use in the last trimester of pregnancy is contraindicated.</p><p>The onset of labour may be delayed and the duration increased with an increased bleeding</p><p>tendency in both mother and child (see section 4.3). NSAIDs should not be used during the</p><p>first two trimesters of pregnancy or labour unless the potential benefit to the patient</p><p>outweighs the potential risk to foetus.</p><p>Lactation</p><p>Like other NSAIDs, diclofenac passes into breast milk in small amounts. Therefore</p><p>Diclofenac should not be administered during breast feeding in order to avoid undesirable</p><p>effects in the infant (see section 5.2).</p><p>Fertility</p><p>As with other NSAIDs, the use of diclofenac may impair female fertility and is not</p><p>recommended in women attempting to conceive. In women who may have difficulties</p><p>conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac</p><p>should be considered.</p><p>See section 4.4 regarding female fertility.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are</p><p>possible after taking NSAIDs. If affected, patients should not drive or operate machinery.</p><table border="0" cellpadding="0" style="width:620px"><tbody><tr><td>&nbsp;</td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellpadding="0" style="width:626px"><tbody><tr><td>&nbsp;</td><td><p>&nbsp;</p><p>Adverse reactions (Table 1) are ranked under heading of frequency, the most frequent first, using the following convention: very common: (&gt;1/10); common (&ge;1/100, &lt;1/10); uncommon (&ge;1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1,000); very rare (&lt;1/10,000); Not known: cannot be estimated from the available data.&nbsp;</p><p><strong>&nbsp;Table1</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Thrombocytopenia, leukopenia, anaemia (including haemolytic and aplastic anaemia), Agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock).</p><p>Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Visual disturbance, vision blurred, diplopia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Very rare</p></td><td style="vertical-align:top"><p>Vertigo.</p><p>Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Palpitations, chest pain, cardiac failure, myocardial infarction.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hypertension, vasculitis.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Asthma (including dyspnoea).</p><p>Pneumonitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence, anorexia.</p><p>&nbsp;</p><p>Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic, melaena, gastrointestinal ulcer (with or without bleeding or perforation).</p><p>&nbsp;</p><p>Colitis (including haemorrhagic colitis</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>and exacerbation of ulcerative colitis or</p><p>Crohn&#39;s disease), constipation, Stomatitis</p><p>(including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Transaminases increased.</p><p>Hepatitis, jaundice, liver disorder. Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Rash.</p><p>Urticaria.</p><p>Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura , allergic purpura, pruritus.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr></tbody></table><p>General disorders and administration site conditions</p><p>Rare Oedema</p><p>Reproductive system and breast disorders</p><p>Very rare Impotence</p><p>&nbsp;</p><p>&nbsp;</p><p>Clinical trial and epidemiological data suggest that use of diclofenac, particularly at high doses (150 mg daily) and in long term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see 4.4).</p><p>The following undesirable effects include those reported with either short-term or long-term use.</p></td><td>&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>To report any side effects</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>National Pharmacovigilance &amp; Drug Safety Center (NPC)</p><p>Fax: +966-11-205-7662</p><p>Call NPC at: +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>Toll free phone: 8002490000</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: www.sfda.gov.sa/npc</p><p>&middot;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>a) Symptoms</p><p>There is no typical clinical picture resulting from diclofenac over dosage. Symptoms include</p><p>headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, rarely diarrhea, dizziness,</p><p>disorientation, excitation, coma, drowsiness, tinnitus, fainting, occasionally convulsions. In rare</p><p>cases of significant poisoning acute renal failure and liver damage are possible.</p><p>b) Therapeutic measure</p><p>Patients should be treated symptomatically as required.</p><p>Within one hour of ingestion of a potentially toxic amount, activated charcoal should be</p><p>considered. Alternatively, in adults, gastric lavage should be considered within one hour of</p><p>ingestion of a potentially life-threatening overdose.</p><p>Good urine output should be ensured. Special measures such as forced diuresis, dialysis or</p><p>haemo-perfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to</p><p>high protein binding and extensive metabolism.</p><p>Renal and liver function should be closely monitored.</p><p>Patients should be observed for at least four hours after ingestion of potentially toxic amounts.</p><p>Frequent or prolonged convulsions should be treated with intravenous diazepam. Supportive</p><p>measures should be given for complications such as hypotension, renal failure, gastrointestinal</p><p>disorder, and respiratory depression.</p><p>Other measures may be indicated by the patient&#39;s clinical condition.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Non-steroidal anti-inflammatory drug (NSAID).</p><p>ATC code: M01A B05</p><p>Diclofenac Potassium tablets contain the potassium salt of diclofenac, a non-steroidal</p><p>compound with pronounced and clinically demonstrable analgesic, anti-inflammatory and</p><p>anti-pyretic properties.</p><p>Diclofenac is a potent inhibitor of prostaglandin biosynthesis and a modulator of</p><p>arachidonic acid release and uptake.</p><p>Diclofenac Potassium tablets have a rapid onset of action and are therefore suitable for the</p><p>treatment of acute episodes of pain and inflammation.</p><p>In migraine attacks Diclofenac Potassium tablets have been shown to be effective in</p><p>relieving the headache and in improving the accompanying symptom of nausea.</p><p>Diclofenac in vitro does not suppress proteoglycan biosynthesis in cartilage at</p><p>concentrations equivalent to the concentrations reached in human beings.</p><p>To report any side effect(s)</p><p>&bull; Saudi Arabia:</p><p>National Pharmacovigilance and Drug Safety Center (NPC)</p><p>Fax: +966-11-205-7662</p><p>Call NPC at +966-11-2038222</p><p>Exts: 2317-2356-2353-2354-2334-2340</p><p>Toll free phone: 8002490000</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Diclofenac is rapidly and completely absorbed from sugar-coated tablets. Food intake does not</p><p>affect absorption.</p><p>Peak plasma concentration after one 50 mg sugar-coated tablet was 3.9 &mu;mol/l after 20-60</p><p>minutes. The plasma concentrations show a linear relationship to the size of the dose.</p><p>Diclofenac undergoes first-pass metabolism and is extensively metabolised.</p><p>Distribution</p><p>Diclofenac is highly bound to plasma proteins (99.7%), chiefly albumin (99.4%)</p><p>Diclofenac was detected in a low concentration (100ng/mL) in breast milk in one nursing</p><p>mother. The estimated amount ingested by an infant consuming breast milk is equivalent to a</p><p>0.03 mg/kg/day dose (see section 4.6).</p><p>Elimination</p><p>The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 ml/min (mean &plusmn; SD).</p><p>The terminal half-life in plasma is 1 &ndash; 2 hours.</p><p>Repeated oral administration of Diclofenac Potassium tablets for 8 days in daily doses of 50 mg</p><p>t.d.s does not lead to accumulation of diclofenac in the plasma.</p><p>Approx. 60% of the dose administered is excreted in the urine in the form of metabolites, and</p><p>less than 1% as unchanged substance. The remainder of the dose is eliminated as metabolites</p><p>through the bile in the faeces.</p><p>Biotransformation</p><p>The biotransformation of diclofenac involves partly glucuronidation of the intact molecule but</p><p>mainly single and multiple hydroxylation followed by glucuronidation.</p><p>Characteristics in patients</p><p>The age of the patient has no influence on the absorption, metabolism, or excretion of diclofenac.</p><p>In patients suffering from renal impairment, no accumulation of the unchanged active substance</p><p>can be inferred from the single-dose kinetics when applying the usual dosage schedule. At a</p><p>creatinine clearance of &lt;10 ml/min the theoretical steady-state plasma levels of metabolites are</p><p>about four times higher than in normal subjects. However, the metabolites are ultimately cleared</p><p>through the bile.</p><p>In the presence of impaired hepatic function (chronic hepatitis, non-decompensated cirrhosis) the</p><p>kinetics and metabolism are the same as for patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Relevant information on the preclinical safety of Diclofenac Potassium Tablets is included</p><p>in previous sections of this Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Starch Glycolate</p><p>Talc</p><p>Colloidal Silicone Dioxide</p><p>Magnesium stearate</p><p>Methocel E6</p><p>plyethylene Glycol 4000</p><p>Titanium Dioxide</p><p>Ferric Oxide Red</p><p>Simethicone Emulsion</p><p>Copovidone</p><p>Dibasic Calcium Phosphate Anhydrous</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellpadding="0" style="width:100%"><tbody><tr><td>&nbsp;</td><td><p>Not applicable.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Two Aluminum-PVC/PVDC blisters of 10 tablets each, packed in printed carton with folded leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tabuk Pharmaceutical Mfg. Co.
Astra industrial group building.
Salah Aldain Road, King abdulaziz Area.
Riyadh,  Saudi Arabia
P.O.Box 28170  Riyadh  11437

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                February 2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>